The yeast Kex2 protease is regarded as the prototype of the eukaryotic family of subtilisin-like serine proteases involved in processing after dibasic amino acid sequences. Here we investigate the specificity of Kex2 using recombinant human proalbumin variants. Proalbumins with the processing site sequences Arg-Arg and Lys-Arg were cleaved after the dibasic sequence at approximately the same rate by Kex2 in vitro, and yeast expressing either of these sequences secreted mature albumin into the culture medium. As expected, the Arg-Gly-Val-PheHis-Arg-albumin (proalbumin Lille) was not a substrate for Kex2 and neither was the Arg-Gly-Arg-Phe-His-Arg-albumin.
INTRODUCTION
Endoproteolytic cleavage of precursor polypeptides targeted to the secretory pathway is a common post-translational event.
Cleavage on the carboxyl side of pairs of basic residues occurs in a diverse range of precursors including plasma proteins, peptide hormones, neuropeptides, growth factors and receptors. The Saccharomyces cerevisiae Kex2 protease (kexin) (EC 3.4.21.61) was the first enzyme proven by biochemical and genetic means to cleave proproteins at dibasic sites [1, 2] . The Kex2 gene sequence [3] showed that the predicted protease was related to the subtilisin family of serine proteases and that it encoded an 814-amino-acid type-I membrane protein with six structural domains. The transcript is a Ca2+-dependent serine protease and in the yeast is involved in the proteolytic maturation of killer toxin and amating factor by cleaving after -Arg-Arg-, -Lys-Arg-and possibly -Pro-Arg-sequences [1] .
There are striking similarities between the processing of mammalian proproteins and the endogenous substrates of Kex2. The discovery over the last five years of mammalian homologues of Kex2 (e.g. furin, PC2, PC1/3, PACE4, etc) suggests conservation of this enzymic mechanism throughout eukaryotic evolution (for recent reviews see [4] [5] [6] ). There is 40-65 % identity between the catalytic domains of members of this superfamily. However, the sequence similarity between Kex2 and the mammalian convertases finishes at the end of the P-domain which is also essential for activity [7] . Further evidence for the similarity of the yeast and mammalian proteases has come from the demonstration that Kex2 can correctly cleave a number of mammalian proproteins including human proinsulin [8] , human proalbumin [9] , mouse pro-opiomelanocortin [10] , human protein C precursor [11] , human pro-von Willebrand Factor [12] , rat proinsulin I [13] and human parainfluenza virus type-3 F protein In contrast to the mammalian endoproteases furin and the hepatic proalbumin convertase, the Kex2 protease was adversely affected by a P4 arginine. There was an 85 % decrease in the cleavage of Arg-Gly-Arg-Phe-Arg-Arg-albumin compared with normal; also chicken proalbumin with an Arg-Phe-Ala-Arg processing site sequence was not a substrate for Kex2. A P1' arginine had a marked negative effect on processing and Nterminal sequence analysis confirmed that cleavage was occurring at the PI-PI' bond. The sequence context surrounding the classical dibasic site is critical in determining susceptibility to cleavage by the Kex2 protease. [14] . This confirms that Kex2 is an appropriate model for the mammalian dibasic-directed proprotein convertases.
Proalbumin is cleaved by a Ca2+-dependent Kex2-like membrane-bound protease in hepatocyte Golgi membranes [15] . We have previously shown that this activity and the Kex2 protease have similar, but not identical, specificities for human proalbumin and a number of naturally occurring proalbumin variants [9, 16] , thus demonstrating that Kex2 mimics the properties of a human proalbumin convertase.
Specificity studies using fluorogenic peptides and overexpression with potential substrates have indicated that the primary specificity determinants for Kex2 are the P1 and P2 residues. It has, however, been shown that overexpression can give a false impression of an enzyme's substrate specificity [17] , and the cleavage of small peptide substrates may not be fully representative of native proproteins. To circumvent these difficulties we have investigated the in vivo and in vitro specificity of the Kex2 protease by expressing various human proalbumin variants in kex2 + and kex2 -S. cerevisiae strains. We further define the contribution of -1,-2 and -1, -4 dibasic configurations to processing efficiency by determining the relative cleavage rates of human proalbumin (Arg-Gly-Val-Phe-ArgArg-alb) and chicken proalbumin (Arg-Asp-Leu-Gln-Arg-PheAla-Arg-alb) in vitro.
MATERIALS AND METHODS Mutagenesis A human preproalbumin cDNA in the yeast expression vector pAB23 [18] (Figure 1) phosphate dehydrogenase promoter and terminator was subcloned into pBLUESCRIPT II SK(-) (Stratagene). Oligonucleotide-directed mutagenesis was carried out on singlestranded uracil-containing templates [19] using primers ( Amino acid sequence analysis
After agarose gel electrophoresis proteins were transferred to a Pro-Blott membrane (ABI) and sequenced on an ABI 471A Protein Sequencer according to the manufacturer's protocols.
Source of Kex2 protease
The Kex2 protease was obtained as a membrane extract from S. cerevisiae strain AB100 overproducing the protease from a multicopy plasmid pAB230 [16] . Yeast were grown to midlogarithmic phase and the cells harvested by centrifugation and broken by glass bead lysis in 50 mM Hepes/KOH (pH 7.6). Cell debris was removed by centrifugation at 5000 g for 15 min at 4°C, and membranes were pelleted by centrifugation at 100000 g for 90 min at 4 'C. These membranes were resuspended in 50 mM Hepes/Tris (pH 7.6) containing 1 % Triton X-100 and stored at -80 'C.
Purfflcation and lodinatlon of human and chicken proalbumins
Human proalbumin was isolated from the plasma of a patient with circulating proalbumin [21] and chicken proalbumin was isolated from liver microsomes as previously described [22] . lodination was carried out by the method of Hunter [23] .
Assay of Kex2 activity Kex2-enriched membrane preparations (0.6,ug of protein/assay) were incubated with 2 ug of expressed proalbumin in a total volume of 5 j1 of 50 mM Mes, pH 6.5/1 mM Ca2+/1 % Triton X-100 at 30 'C. Incubations were stopped after the specified times by the addition of EDTA to 10 mM. When 125I-labelled chicken or human proalbumin Conversion of proalbumin to albumin was analysed by agarose gels (1 %) electrophoresed in Tris/barbital buffer (38 mM Tris, 46 mM sodium barbital, 16 mM diethyl barbituric acid), pH 8.6. 1251 or 63Ni autoradiography was carried out as previously described [21] .
RESULTS
In vivo processing of proalbumin variants by S. cerevisiae strain AB110 Normal human proalbumin and the proalbumin variants listed in Table 2 were expressed in the kex2+ yeast strain AB110. Ammonium sulphate precipitates of the culture supernatants were analysed by agarose gel electrophoresis (Figure 2 ). This acid sequence analysis showed that the processing site was the PI-Pl' bond. 
In vitro processing of proalbumin variants by Kex2
In order to determine the relative processing rates of the various proalbumins, the purified precursors were incubated with membranes isolated from yeast overexpressing the Kex2 protease. The processing of each proalbumin variant was followed by agarose gel electrophoresis over an 8 h incubation period ( Figure  3 ). There was very similar processing of both the normal and -2Lys proalbumins over this time course, with approximately 90 % processing of normal and 70 % processing of the -2Lys proalbumin (lanes 1-3 and 4-6 respectively). There was no processing ofeither the -2His or the -2His -4Arg proalbumins (lanes 7-9 and 13-15 respectively) and only minor cleavage of both the -4Arg and + lArg proalbumin variants, with the overall cleavage rate less than 5 % of the rate observed for normal proalbumin (lanes 10-12 and 16-18). The variation in band intensity in lanes 10-12 was due to a loading artifact and other experiments confirmed the cleavage rate of this variant. The processing site for normal, -2Lys, -4Arg and + lArg proalbumins was confirmed as being at the PI-PI' site by electrophoretic mobility and 63Ni autoradiography (not shown).
Cleavage after -1,-4 dibasic sites Since the presence of a -4 arginine had a significant deleterious effect on the ability of the Kex2 protease to cleave human proalbumin we further explored the apparent negative contribution of a P4 arginine by investigating the Kex2-catalysed processing of chicken proalbumin. Unlike human proalbumin, which has a classical Arg-Gly-Val-Phe-Arg-Arg dibasic sequence, chicken proalbumin has a -1, -4 dibasic site and a propeptide sequence ofArg-Asn-Leu-Gln-Arg-Phe-Ala-Arg. Figure 4 shows that human proalbumin underwent rapid hydrolysis with 50 % 
DISCUSSION
The expression of normal human proalbumin in Kex2-positive yeast leads to the secretion of correctly cleaved mature albumin into the culture medium. Changing the dibasic processing site from Arg-Arg to Lys-Arg had no effect on either the amount of albumin secreted or the extent to which it was processed. We had previously shown, in vitro, that the circulating variant proalbumin Lille (-2Arg -* His) was not a substrate for the Kex2 protease [16] . When a recombinant proalbumin containing this mutation was expressed in strain AB 110 (kex2 +), analysis of the culture supernatant confirmed it was not processed, and also showed that the unprocessed proalbumin was poorly exported from these cells. An identical result was obtained with the corresponding double mutant -2His -4Arg (Arg-Phe-His-Arg). The -4Arg proalbumin with an Arg-Phe-Arg-Arg processing site sequence was present as mature albumin in the culture medium but its low yield implied it was poorly exported from the cells, perhaps because of inefficient intracellular cleavage. We were surprised at the low level of secretion of the three unprocessed or poorly processed variants, especially since all the proalbumins were secreted equally well from the Kex2-deficient strain. One interpretation of this result is that if processing does not occur the unprocessed proproteins are partially prevented from being secreted; however, the mechanism by which this occurs is not known.
To obtain more precise data on the relative cleavage rates of the recombinant proalbumins, and to compare this with the known specificity of Kex2 for naturally occurring proalbumin variants, we expressed and purified uncleaved recombinant proalbumins from the supernatants of Kex2-deficient ABl 18 cultures. Indeed the complete failure of processing in this strain confirms that Kex2 and not another endoprotease such as YAP3 [24] is responsible for proalbumin cleavage.
As expected from their expression in AB110, normal proalbumin and the -2Lys proalbumin were processed at similar rates by the Kex2-enriched membranes. This is also consistent with our observation that Kex2-enriched membranes cleave aminoethylated proalbumin Kaikoura (AE-Cys-Arg), with a lysine analogue at P2, almost as efficiently as normal human proalbumin [16] . The lack ofprocessing of the -2His proalbumin was in complete agreement with our earlier result with the natural variant proalbumin Lille. The -2His -4Arg proalbumin with an Arg-Phe-His-Arg processing site sequence was not a substrate for Kex2. However, we have found that furin-catalysed cleavage of -1, -4 dibasic sites is inhibited by a P2 histidine [25] .
Contrary to previous reports [11 -13] we found that residues beyond P1 and P2 had a profound effect on the efficiency of proalbumin processing by Kex2. The recombinant proalbumin with the Arg-Phe-Arg-Arg processing site was a poor substrate for Kex2 in vitro, consistent with the low yield of mature albumin in the medium of strain AB 110 yeast transformed with -4Arg proalbumin. This is in marked contrast to the beneficial effect of a P4 arginine on processing by furin [25] or the hepatic proalbumin convertase (E. C. Ledgerwood and S. 0. Brennan, unpublished work). The predicted inability of Kex2 to cleave -1, -4 diarginyl sequences was confirmed by its inability to cleave native chicken proalbumin with a processing site of Arg-PheAla-Arg, again in marked contrast to the hepatic proalbumin convertase which cleaves this substrate five times faster than human proalbumin [26] . In known endogenous Kex2 substrates there is a preference for aliphatic residues at P4 [27] . Possible explanations for the negative impact of a P4 arginine may be gained by comparing the putative substrate-binding region of Kex2 with that of furin which has been modelled on the crystal structures of thermitase and subtilisin BPN' [28] . Although Kex2 and furin have the same total number of acidic residues in their proposed substrate-binding pockets, the locations differ, with Kex2 having one extra acidic residue in the S2 pocket and one less in the S4 pocket. When one of the P4 acidic residues in furin was mutated the affinity increased for a Lys-Arg site and decreased for an Arg-Xaa-Xaa-Arg site [29] .
In vitro the + lArg proalbumin was a poor substrate for Kex2, which was surprising given that processing occurred in the kex2+ strain in vivo. This highlights the conflicting results that can arise from in vitro versus in vivo observations. A possible explanation for the high yield of processed albumin by strain ABl 10 (kex2+ ) is that some other endoprotease cleaved between the P1 and P1' arginines and that the activity of this protease is kex2-dependent. Thus processing would not occur in the kex2-strain as was observed.
Clearly, however, a P1' arginine has an unfavourable effect on in vitro processing by Kex2. We have observed a similar effect with the mammalian endoprotease furin which will not cleave proalbumin peptides with a P1' lysine [25] . In the current study our prediction was that the processing site would shift to the P1'-P2' peptide bond since many mammalian proproteins have a multibasic processing site terminating in a C-terminal arginine. However, this did not occur and the limited processing occurred exclusively between the P1 and P1' arginine residues. The steric conformation of proalbumin may mean that the potential new site cannot fit correctly into the substrate-binding region of Kex2. Alternatively the new site would have a histidine at P2', and Hosaka et al. [30] have suggested that for furin a hydrophobic residue is preferred at P2'. This may also be true for Kex2, since on the basis of the putative model of furin's catalytic domain the important S2' residues are conserved in Kex2. Finally, Kex2 may not process when there is a P3 arginine. We have observed that P3 arginine is slightly unfavourable for processing by furin (S. 0. Brennan and K. Nakayama, unpublished work).
As the first proven member of the eukaryotic family of subtilisin-like serine proteases, Kex2 has contributed significantly to our understanding of mammalian proprotein processing. The data presented here show that Kex2 has its own distinct substrate specificity. The principal criterion which distinguishes it from the archetypal mammalian enzymes furin and the proalbumin convertase is the negative effect of the P4 arginine on Kex2 processing compared with its critical importance for rapid cleavage by these mammalian endoproteases.
